ID   TBB4B_HUMAN             Reviewed;         445 AA.
AC   P68371; A2BFA2; P05217;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   28-JAN-2026, entry version 195.
DE   RecName: Full=Tubulin beta-4B chain;
DE   AltName: Full=Tubulin beta-2 chain;
DE   AltName: Full=Tubulin beta-2C chain;
GN   Name=TUBB4B; Synonyms=TUBB2C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3999141; DOI=10.1016/0022-2836(85)90023-3;
RA   Lewis S.A., Gilmartin M.E., Hall J.L., Cowan N.J.;
RT   "Three expressed sequences within the human beta-tubulin multigene family
RT   each define a distinct isotype.";
RL   J. Mol. Biol. 182:11-20(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Cervix, Lung, Lymph, Muscle, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [5]
RP   PHOSPHORYLATION AT SER-172.
RX   PubMed=16371510; DOI=10.1091/mbc.e05-07-0621;
RA   Fourest-Lieuvin A., Peris L., Gache V., Garcia-Saez I., Juillan-Binard C.,
RA   Lantez V., Job D.;
RT   "Microtubule regulation in mitosis: tubulin phosphorylation by the cyclin-
RT   dependent kinase Cdk1.";
RL   Mol. Biol. Cell 17:1041-1050(2006).
RN   [6]
RP   GLYCYLATION.
RX   PubMed=19524510; DOI=10.1016/j.cell.2009.05.020;
RA   Rogowski K., Juge F., van Dijk J., Wloga D., Strub J.-M., Levilliers N.,
RA   Thomas D., Bre M.-H., Van Dorsselaer A., Gaertig J., Janke C.;
RT   "Evolutionary divergence of enzymatic mechanisms for posttranslational
RT   polyglycylation.";
RL   Cell 137:1076-1087(2009).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-58, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=20191564; DOI=10.1002/cm.20436;
RA   Leandro-Garcia L.J., Leskela S., Landa I., Montero-Conde C.,
RA   Lopez-Jimenez E., Leton R., Cascon A., Robledo M., Rodriguez-Antona C.;
RT   "Tumoral and tissue-specific expression of the major human beta-tubulin
RT   isotypes.";
RL   Cytoskeleton 67:214-223(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-55, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   GLUTAMYLATION.
RX   PubMed=26875866; DOI=10.1016/j.cell.2016.01.019;
RA   Valenstein M.L., Roll-Mecak A.;
RT   "Graded control of microtubule severing by tubulin glutamylation.";
RL   Cell 164:911-921(2016).
RN   [13] {ECO:0007744|PDB:7UNG}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.60 ANGSTROMS).
RX   PubMed=36191189; DOI=10.1073/pnas.2207605119;
RA   Gui M., Croft J.T., Zabeo D., Acharya V., Kollman J.M., Burgoyne T.,
RA   Hoog J.L., Brown A.;
RT   "SPACA9 is a lumenal protein of human ciliary singlet and doublet
RT   microtubules.";
RL   Proc. Natl. Acad. Sci. U.S.A. 119:e2207605119-e2207605119(2022).
RN   [14]
RP   INVOLVEMENT IN LCAEOD, VARIANTS LCAEOD CYS-391 AND HIS-391, AND
RP   CHARACTERIZATION OF VARIANTS LCAEOD CYS-391 AND HIS-391.
RX   PubMed=29198720; DOI=10.1016/j.ajhg.2017.10.010;
RA   Luscan R., Mechaussier S., Paul A., Tian G., Gerard X.,
RA   Defoort-Dellhemmes S., Loundon N., Audo I., Bonnin S., LeGargasson J.F.,
RA   Dumont J., Goudin N., Garfa-Traore M., Bras M., Pouliet A., Bessieres B.,
RA   Boddaert N., Sahel J.A., Lyonnet S., Kaplan J., Cowan N.J., Rozet J.M.,
RA   Marlin S., Perrault I.;
RT   "Mutations in TUBB4B cause a distinctive sensorineural disease.";
RL   Am. J. Hum. Genet. 101:1006-1012(2017).
CC   -!- FUNCTION: Tubulin is the major constituent of microtubules, a cylinder
CC       consisting of laterally associated linear protofilaments composed of
CC       alpha- and beta-tubulin heterodimers. Microtubules grow by the addition
CC       of GTP-tubulin dimers to the microtubule end, where a stabilizing cap
CC       forms. Below the cap, tubulin dimers are in GDP-bound state, owing to
CC       GTPase activity of alpha-tubulin.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P68363};
CC   -!- SUBUNIT: Dimer of alpha and beta chains. A typical microtubule is a
CC       hollow water-filled tube with an outer diameter of 25 nm and an inner
CC       diameter of 15 nM. Alpha-beta heterodimers associate head-to-tail to
CC       form protofilaments running lengthwise along the microtubule wall with
CC       the beta-tubulin subunit facing the microtubule plus end conferring a
CC       structural polarity. Microtubules usually have 13 protofilaments but
CC       different protofilament numbers can be found in some organisms and
CC       specialized cells. Component of sperm flagellar doublet microtubules.
CC       {ECO:0000250|UniProtKB:P68372}.
CC   -!- INTERACTION:
CC       P68371; Q5S007: LRRK2; NbExp=3; IntAct=EBI-351356, EBI-5323863;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:P68372}. Cytoplasm, cytoskeleton, flagellum
CC       axoneme {ECO:0000250|UniProtKB:P68372}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:20191564}.
CC   -!- DOMAIN: The highly acidic C-terminal region may bind cations such as
CC       calcium.
CC   -!- DOMAIN: The MREI motif is common among all beta-tubulin isoforms and
CC       may be critical for tubulin autoregulation.
CC       {ECO:0000250|UniProtKB:P07437}.
CC   -!- PTM: Some glutamate residues at the C-terminus are polyglutamylated,
CC       resulting in polyglutamate chains on the gamma-carboxyl group
CC       (PubMed:26875866). Polyglutamylation plays a key role in microtubule
CC       severing by spastin (SPAST). SPAST preferentially recognizes and acts
CC       on microtubules decorated with short polyglutamate tails: severing
CC       activity by SPAST increases as the number of glutamates per tubulin
CC       rises from one to eight, but decreases beyond this glutamylation
CC       threshold (PubMed:26875866). Glutamylation is also involved in cilia
CC       motility (By similarity). {ECO:0000250|UniProtKB:P99024,
CC       ECO:0000269|PubMed:26875866}.
CC   -!- PTM: Some glutamate residues at the C-terminus are monoglycylated but
CC       not polyglycylated due to the absence of functional TTLL10 in human.
CC       Monoglycylation is mainly limited to tubulin incorporated into cilia
CC       and flagella axonemes, which is required for their stability and
CC       maintenance. Flagella glycylation controls sperm motility. Both
CC       polyglutamylation and monoglycylation can coexist on the same protein
CC       on adjacent residues, and lowering glycylation levels increases
CC       polyglutamylation, and reciprocally. {ECO:0000250|UniProtKB:P07437,
CC       ECO:0000305|PubMed:19524510}.
CC   -!- PTM: Phosphorylated on Ser-172 by CDK1 during the cell cycle, from
CC       metaphase to telophase, but not in interphase. This phosphorylation
CC       inhibits tubulin incorporation into microtubules.
CC       {ECO:0000269|PubMed:16371510}.
CC   -!- DISEASE: Leber congenital amaurosis with early-onset deafness (LCAEOD)
CC       [MIM:617879]: An autosomal dominant disease characterized by severe
CC       retinal degeneration and sensorineural hearing loss. Symptoms occur
CC       within the first decade of life. Onset at birth is observed in some
CC       patients. {ECO:0000269|PubMed:29198720}. Note=The disease is caused by
CC       variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the tubulin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X02344; CAA26203.1; -; Genomic_DNA.
DR   EMBL; BX255925; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001911; AAH01911.1; -; mRNA.
DR   EMBL; BC002783; AAH02783.1; -; mRNA.
DR   EMBL; BC002885; AAH02885.1; -; mRNA.
DR   EMBL; BC004188; AAH04188.1; -; mRNA.
DR   EMBL; BC007889; AAH07889.1; -; mRNA.
DR   EMBL; BC012835; AAH12835.1; -; mRNA.
DR   EMBL; BC019359; AAH19359.1; -; mRNA.
DR   EMBL; BC019829; AAH19829.1; -; mRNA.
DR   EMBL; BC039175; AAH39175.1; -; mRNA.
DR   EMBL; BC071889; AAH71889.1; -; mRNA.
DR   CCDS; CCDS7039.1; -.
DR   PIR; I38370; I38370.
DR   RefSeq; NP_006079.1; NM_006088.6.
DR   PDB; 7UN1; EM; 6.00 A; AB/AD/AF/BA/BD/BF/CB/CD/CF/DB/DD/DF/EB/ED/EF/FD/FF/FH/GD/GF/GH/HD/HF/HH/ID/IF/IH/JD/JF/KD=1-445.
DR   PDB; 7UNG; EM; 3.60 A; AB/AD/AF/AH/AJ/AL/BB/BD/BF/BH/BJ/BL/CB/CD/CF/CH/CJ/CL/DB/DD/DF/DH/DJ/DL/EB/ED/EF/EH/EJ/EL=1-445.
DR   PDB; 8J07; EM; 4.10 A; AB/AD/AF/AH/AJ/AL/AN/AP/AR/AT/AV/AX/BB/BD/BF/BH/BJ/BL/BN/BP/BR/BT/BV/BX/CB/CD/CF/CH/CJ/CL=1-445.
DR   PDB; 8SH7; EM; 2.80 A; B=1-445.
DR   PDBsum; 7UN1; -.
DR   PDBsum; 7UNG; -.
DR   PDBsum; 8J07; -.
DR   PDBsum; 8SH7; -.
DR   AlphaFoldDB; P68371; -.
DR   EMDB; EMD-26611; -.
DR   EMDB; EMD-26624; -.
DR   EMDB; EMD-35888; -.
DR   EMDB; EMD-40480; -.
DR   SMR; P68371; -.
DR   BioGRID; 115656; 732.
DR   CORUM; P68371; -.
DR   FunCoup; P68371; 1766.
DR   IntAct; P68371; 321.
DR   MINT; P68371; -.
DR   STRING; 9606.ENSP00000341289; -.
DR   BindingDB; P68371; -.
DR   ChEMBL; CHEMBL1848; -.
DR   DrugBank; DB00518; Albendazole.
DR   DrugBank; DB05147; CYT997.
DR   DrugBank; DB01873; Epothilone D.
DR   DrugBank; DB00643; Mebendazole.
DR   DrugBank; DB04910; Oxibendazole.
DR   DrugBank; DB03010; Patupilone.
DR   DrugBank; DB12695; Phenethyl Isothiocyanate.
DR   DrugCentral; P68371; -.
DR   GlyCosmos; P68371; 6 sites, 1 glycan.
DR   GlyGen; P68371; 7 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (6 sites).
DR   iPTMnet; P68371; -.
DR   MetOSite; P68371; -.
DR   PhosphoSitePlus; P68371; -.
DR   SwissPalm; P68371; -.
DR   BioMuta; TUBB4B; -.
DR   DMDM; 55977480; -.
DR   OGP; P05217; -.
DR   REPRODUCTION-2DPAGE; IPI00007752; -.
DR   jPOST; P68371; -.
DR   MassIVE; P68371; -.
DR   PaxDb; 9606-ENSP00000341289; -.
DR   PeptideAtlas; P68371; -.
DR   PRIDE; P68371; -.
DR   ProteomicsDB; 57535; -.
DR   Pumba; P68371; -.
DR   TopDownProteomics; P68371; -.
DR   Antibodypedia; 4391; 148 antibodies from 25 providers.
DR   DNASU; 10383; -.
DR   Ensembl; ENST00000340384.5; ENSP00000341289.4; ENSG00000188229.7.
DR   GeneID; 10383; -.
DR   KEGG; hsa:10383; -.
DR   MANE-Select; ENST00000340384.5; ENSP00000341289.4; NM_006088.6; NP_006079.1.
DR   UCSC; uc004cmh.2; human.
DR   AGR; HGNC:20771; -.
DR   ClinPGx; PA142670672; -.
DR   CTD; 10383; -.
DR   DisGeNET; 10383; -.
DR   GeneCards; TUBB4B; -.
DR   HGNC; HGNC:20771; TUBB4B.
DR   HPA; ENSG00000188229; Low tissue specificity.
DR   MalaCards; TUBB4B; -.
DR   MIM; 602660; gene.
DR   MIM; 617879; phenotype.
DR   OpenTargets; ENSG00000188229; -.
DR   Orphanet; 65; Leber congenital amaurosis.
DR   VEuPathDB; HostDB:ENSG00000188229; -.
DR   eggNOG; KOG1375; Eukaryota.
DR   GeneTree; ENSGT00940000154394; -.
DR   HOGENOM; CLU_015718_1_1_1; -.
DR   InParanoid; P68371; -.
DR   OMA; WVPRSVN; -.
DR   OrthoDB; 1662883at2759; -.
DR   PAN-GO; P68371; 6 GO annotations based on evolutionary models.
DR   PhylomeDB; P68371; -.
DR   PathwayCommons; P68371; -.
DR   Reactome; R-HSA-1445148; Translocation of SLC2A4 (GLUT4) to the plasma membrane.
DR   Reactome; R-HSA-190840; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane.
DR   Reactome; R-HSA-190861; Gap junction assembly.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-389957; Prefoldin mediated transfer of substrate to CCT/TriC.
DR   Reactome; R-HSA-389960; Formation of tubulin folding intermediates by CCT/TriC.
DR   Reactome; R-HSA-389977; Post-chaperonin tubulin folding pathway.
DR   Reactome; R-HSA-437239; Recycling pathway of L1.
DR   Reactome; R-HSA-5610787; Hedgehog 'off' state.
DR   Reactome; R-HSA-5617833; Cilium Assembly.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-5620924; Intraflagellar transport.
DR   Reactome; R-HSA-5626467; RHO GTPases activate IQGAPs.
DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-6807878; COPI-mediated anterograde transport.
DR   Reactome; R-HSA-6811434; COPI-dependent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-6811436; COPI-independent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-68877; Mitotic Prometaphase.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   Reactome; R-HSA-8955332; Carboxyterminal post-translational modifications of tubulin.
DR   Reactome; R-HSA-9609690; HCMV Early Events.
DR   Reactome; R-HSA-9609736; Assembly and cell surface presentation of NMDA receptors.
DR   Reactome; R-HSA-9619483; Activation of AMPK downstream of NMDARs.
DR   Reactome; R-HSA-9646399; Aggrephagy.
DR   Reactome; R-HSA-9648025; EML4 and NUDC in mitotic spindle formation.
DR   Reactome; R-HSA-9668328; Sealing of the nuclear envelope (NE) by ESCRT-III.
DR   Reactome; R-HSA-983189; Kinesins.
DR   Reactome; R-HSA-9833482; PKR-mediated signaling.
DR   SignaLink; P68371; -.
DR   SIGNOR; P68371; -.
DR   Agora; ENSG00000188229; -.
DR   BioGRID-ORCS; 10383; 219 hits in 1168 CRISPR screens.
DR   CD-CODE; 91857CE7; Nucleolus.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; TUBB4B; human.
DR   GeneWiki; TUBB2C; -.
DR   GenomeRNAi; 10383; -.
DR   Pharos; P68371; Tclin.
DR   PRO; PR:P68371; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; P68371; protein.
DR   Bgee; ENSG00000188229; Expressed in right testis and 208 other cell types or tissues.
DR   GO; GO:0005879; C:axonemal microtubule; IDA:UniProtKB.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1903561; C:extracellular vesicle; HDA:UniProtKB.
DR   GO; GO:0045171; C:intercellular bridge; IDA:HPA.
DR   GO; GO:0005874; C:microtubule; IDA:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:HPA.
DR   GO; GO:0072686; C:mitotic spindle; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0036126; C:sperm flagellum; IEA:Ensembl.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:MGI.
DR   GO; GO:0005525; F:GTP binding; IBA:GO_Central.
DR   GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042288; F:MHC class I protein binding; TAS:UniProtKB.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; IBA:GO_Central.
DR   GO; GO:0051082; F:unfolded protein binding; NAS:UniProtKB.
DR   GO; GO:0030317; P:flagellated sperm motility; IEA:Ensembl.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0000278; P:mitotic cell cycle; IBA:GO_Central.
DR   GO; GO:0042267; P:natural killer cell mediated cytotoxicity; NAS:UniProtKB.
DR   CDD; cd02187; beta_tubulin; 1.
DR   FunFam; 1.10.287.600:FF:000006; Tubulin beta chain; 1.
DR   FunFam; 3.30.1330.20:FF:000002; Tubulin beta chain; 1.
DR   FunFam; 3.40.50.1440:FF:000003; Tubulin beta chain; 1.
DR   Gene3D; 1.10.287.600; Helix hairpin bin; 1.
DR   Gene3D; 3.30.1330.20; Tubulin/FtsZ, C-terminal domain; 1.
DR   Gene3D; 3.40.50.1440; Tubulin/FtsZ, GTPase domain; 1.
DR   InterPro; IPR013838; Beta-tubulin_BS.
DR   InterPro; IPR002453; Beta_tubulin.
DR   InterPro; IPR008280; Tub_FtsZ_C.
DR   InterPro; IPR000217; Tubulin.
DR   InterPro; IPR037103; Tubulin/FtsZ-like_C.
DR   InterPro; IPR018316; Tubulin/FtsZ_2-layer-sand-dom.
DR   InterPro; IPR036525; Tubulin/FtsZ_GTPase_sf.
DR   InterPro; IPR023123; Tubulin_C.
DR   InterPro; IPR017975; Tubulin_CS.
DR   InterPro; IPR003008; Tubulin_FtsZ_GTPase.
DR   PANTHER; PTHR11588; TUBULIN; 1.
DR   Pfam; PF00091; Tubulin; 1.
DR   Pfam; PF03953; Tubulin_C; 1.
DR   PRINTS; PR01163; BETATUBULIN.
DR   PRINTS; PR01161; TUBULIN.
DR   SMART; SM00864; Tubulin; 1.
DR   SMART; SM00865; Tubulin_C; 1.
DR   SUPFAM; SSF55307; Tubulin C-terminal domain-like; 1.
DR   SUPFAM; SSF52490; Tubulin nucleotide-binding domain-like; 1.
DR   PROSITE; PS00227; TUBULIN; 1.
DR   PROSITE; PS00228; TUBULIN_B_AUTOREG; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell projection; Cilium; Cytoplasm;
KW   Cytoskeleton; Deafness; Disease variant; Flagellum; GTP-binding;
KW   Isopeptide bond; Leber congenital amaurosis; Magnesium; Metal-binding;
KW   Microtubule; Nucleotide-binding; Phosphoprotein; Proteomics identification;
KW   Reference proteome.
FT   CHAIN           1..445
FT                   /note="Tubulin beta-4B chain"
FT                   /id="PRO_0000048248"
FT   REGION          426..445
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           1..4
FT                   /note="MREI motif"
FT                   /evidence="ECO:0000250|UniProtKB:P07437"
FT   COMPBIAS        429..445
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         11
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q13509"
FT   BINDING         69
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:P68363"
FT   BINDING         69
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P68363"
FT   BINDING         138
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q13509"
FT   BINDING         142
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q13509"
FT   BINDING         143
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q13509"
FT   BINDING         144
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q13509"
FT   BINDING         204
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q13509"
FT   BINDING         226
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q13509"
FT   MOD_RES         55
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         58
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         172
FT                   /note="Phosphoserine; by CDK1"
FT                   /evidence="ECO:0000269|PubMed:16371510"
FT   MOD_RES         438
FT                   /note="5-glutamyl polyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:Q2T9S0"
FT   VARIANT         391
FT                   /note="R -> C (in LCAEOD; affects microtubules
FT                   polymerization; dbSNP:rs1554786802)"
FT                   /evidence="ECO:0000269|PubMed:29198720"
FT                   /id="VAR_080782"
FT   VARIANT         391
FT                   /note="R -> H (in LCAEOD; affects microtubules
FT                   polymerization; dbSNP:rs1554786803)"
FT                   /evidence="ECO:0000269|PubMed:29198720"
FT                   /id="VAR_080783"
FT   STRAND          3..9
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           10..28
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   STRAND          34..36
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           41..43
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           47..49
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   STRAND          51..54
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   TURN            55..57
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   STRAND          58..61
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   STRAND          63..69
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           71..77
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           81..83
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           87..89
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   STRAND          90..92
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           101..105
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           109..124
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   STRAND          128..142
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           143..158
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   STRAND          160..169
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           181..195
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   STRAND          197..202
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           204..213
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           222..241
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   STRAND          244..246
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           250..257
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   STRAND          265..271
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           278..281
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           286..294
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           296..298
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   STRAND          300..302
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           305..307
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   STRAND          310..320
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           323..336
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           338..340
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   STRAND          349..355
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   STRAND          364..371
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           372..374
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           375..389
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   TURN            390..394
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           395..399
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   TURN            400..402
FT                   /evidence="ECO:0007829|PDB:8SH7"
FT   HELIX           406..423
FT                   /evidence="ECO:0007829|PDB:8SH7"
SQ   SEQUENCE   445 AA;  49831 MW;  A552C52822AFA072 CRC64;
     MREIVHLQAG QCGNQIGAKF WEVISDEHGI DPTGTYHGDS DLQLERINVY YNEATGGKYV
     PRAVLVDLEP GTMDSVRSGP FGQIFRPDNF VFGQSGAGNN WAKGHYTEGA ELVDSVLDVV
     RKEAESCDCL QGFQLTHSLG GGTGSGMGTL LISKIREEYP DRIMNTFSVV PSPKVSDTVV
     EPYNATLSVH QLVENTDETY CIDNEALYDI CFRTLKLTTP TYGDLNHLVS ATMSGVTTCL
     RFPGQLNADL RKLAVNMVPF PRLHFFMPGF APLTSRGSQQ YRALTVPELT QQMFDAKNMM
     AACDPRHGRY LTVAAVFRGR MSMKEVDEQM LNVQNKNSSY FVEWIPNNVK TAVCDIPPRG
     LKMSATFIGN STAIQELFKR ISEQFTAMFR RKAFLHWYTG EGMDEMEFTE AESNMNDLVS
     EYQQYQDATA EEEGEFEEEA EEEVA
//
